10^th International Congress on Clinical Virology & Infectious Diseases December 4-5, 2017 Dubai, UAE

Marketing Analysis

Importance & Scope:

Clinical virology is a branch of clinical pathology which consists in isolating and/or in characterizing one or several viruses responsible for some human pathology by various direct or indirect techniques. It also consists in proving the absence of resistance of viruses in treatment antiviral by viral genome sequencing to adapt antiviral therapeutics at best. Clinical Virology 2017 conference is bringing experts from the field of virology for discussion of the latest advances and ideas and to stimulate interdisciplinary interactions.

Conference series puts together the entire eminent Virologists and all Microbiologists across the globe to share their knowledge and views on the respective conference theme.

This range of new uses of virus all stand on the shoulders of the efforts of virologists over generations: the scientific discipline virology has built comprehensive understanding within viral classification, evolution, physiology, and pathogenesis. Applied Virology and Mycology could not make progress without this platform. To unfold the full potentials of what virus and fungi can do for both environment and man we need to strengthen the field of virology and mycology on a global scale.

Analysis

Clinical Virology 2017 welcomes attendees, presenters, and exhibitors from all over the world to Atlanta. We are delighted to invite you all to attend and register for the “ 10th International Congress on Clinical Virology & Infectious Diseases" December 4-5, 2017 in Dubai, UAE.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Clinical Virology 2017, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Clinical Virology 2017 organizing committee are looking forward to meet you in Dubai, UAE.

For more details please visit- http://clinicalvirology.conferenceseries.com/

Tourist Attraction in Dubai

The world Tourist attraction is enormously increasing for Dubai. It attracted 20.53 million International tourists in 2016.

Why Clinical Virology?

The industrial Clinical Virology market is vast and growing, the second largest diagnostics market after clinical diagnostics in test volume and market value. Worldwide more than 85,000 industrial plants conduct almost 2 billion tests each year, this represents a market value of US$ 5,852.4 Million in 2008 and   US$ 9,878.2 Million in 2016 and is expected to grow at CAGR of 8.1% to reach US$ 18,455.0 by 2026 end.

The global market for clinical virology products was valued at $143.5 billion in 2014. The 2016 market has approached $164.7 billion, and projecting the 2020 market, nearly $306 billion, with an annual growth rate of 16.5% from 2015 to 2020.

Virology universities in Dubai

Ø  Amity University

Ø  American University

Ø  Case Western University

Ø  University of Wollongong

Ø  Biotechnology University College

Survey:

Association of  Virology researchers in Dubai

Virology research includes a number of specialties like Anatomical Pathology, Diagnostic Virology, Plant Virology, and many more. Every specialist conducts research related to their respective topic to improve technologies in virology field. In Dubai alone there are approximately around 720 researchers on virology. 

As per the records it is being acknowledged that globally 7.68% are research virologists. UAE said to be one of the top most countries having a large number of Virology researchers.

Societies Associated with Virology

American Society for Virology

European Society for Virology

American Society for Microbiology

Indian Virological Society

European Society for Clinical Virology

Spanish Society for Virology

Australasian Virology Society

Pan-American Society for Clinical Virology

Egyptian Society of Virology

The Japanese Society for Virology

Swiss Society for Microbiology

Pharmaceutical companies producing Clinical Virological drugs

 Actelion Pharmaceuticals  Ltd

 Alliance Pharmaceuticals Ltd

 Beacon Pharmaceuticals Ltd

BHR Pharmaceuticals Ltd

 Chauvin Pharmaceuticals Ltd

Denfleet Pharmaceuticals Ltd

Fournier Pharmaceuticals Ltd

Huntley Pharmaceuticals Ltd

Martindale Pharmaceuticals Ltd

Winthrop Pharmaceuticals UK Ltd

ConferenceSeries Ltd Welcome you to attend the "10^th International Congress on Clinical Virology & Infectious Diseases" which is to be transpired on December 4-5, 2017 in Dubai, UAE. The conference focuses on the quintessence Emerging New Technologies in Clinical Virology & Infectious Diseases. Aforesaid Assemblage implores the participation of enthusiasts from all prominent universities, research centers and institutions, microbiologists, mycologists, virologists, students, scholars, diagnostic companies associations and pharmaceuticals to apprise their research cognitions on entire prospects of this dernier cri and illustrating the novel ameliorations and futuristic technologies in operation for the advanced research on viruses and all Infectious Diseases.

Track 1 : General Virology

The Global Virology Market Overview reported an aggregate of $1485.02 million in 2013 and it is estimated to reach $1932.8 million by the year 2018 at a CAGR of about 5.6%. The market growth of virology is remarkable in North America followed by Europe with a predicted significant CAGR growth of about 7% through the forecast period of 2016-2021 due to advancements in the technological development of rapid, futuristic and portable diagnostic tools and tests owing to the ever-improving healthcare infrastructure, convenience and affordability of these diagnostic tests. Hospitals, Research laboratories and other research centers hold 50% stakes in the global virology market and this proclivity is to continue through the year 2025.

Virology  deals with the study of infectious agents like viruses, viral taxonomy, virulence, viral cultures and genetics. It is a significant part of both microbiology and pathology; but being a part of these applied sciences, the discipline of virology is in itself a huge field with its own sub-fields primarily due to advances in the chemical, physical and biological sciences and they gradually became a means to probe various underlying biochemical processes of cells.

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

9th International Virology Congress and Expo,March13-15,2017 London,UK;10^th World Congress on Virology and Mycology May 11-12,2017 Singapore;8^th World Congress on Virology,November 20-30,2016 San Anthonio,USA;5^th International Conference on HIV/AIDS,STDs and STIs November 13-14,2017 Las Vegas,Neveda,USA; American Society for Virology 2017 Annual Meeting 24-28 June 2017,Madison,United States; ICV2017:19^th International Conference on Virology,Miami,USA,March9-10,2017;GRC Physical Virology Gordon Research Conference,January29-February3,2017; ASM Clinical Virology Symposium,May7-10,2017,Savannah,Georgia; 27^th Annual Meeting of the Society for Virology,22-25 March 2017,Marburg; 4^th World Congress and Expo on Applied Microbiology September 19-21,2016 Las Vegas,USA; 7^th Clinical Microbiology Congress February 27-28,2017 Amsterdam,Netherlands ; 8^th Clinical Microbiology Conference October 26-27,2017 Paris,France; CACMID-AMMI Canada 2017 Annual Conference(Toronto,May 3-6 2017);asm microbe 2017; 27^th European Congress of Clinical Microbiology and Infectious Diseases 2017(ECCMID 2017); FEMS 2017 7^th Congress of European Microbiologists,July 9-13,2017 Valencia,Spain; The Microbiology Society Annual Conference 2017,3-6April 2017.

Track 2 :  Viral Pathogenesis and Prevention

According to the CTMS (Clinical Trial Management System) which predicted the Global Market Overview, 2014-2019, the market which was priced at $844 million in 2013, will grow at a CAGR of 14% by 2019 and will worth an envisaged $1,848.5 million.

Viral pathogenesis is attaining of the disease in the host by viruses gradually. Factors that determine the transmission, viral multiplication, disease/infection development involve complex, intricate and potent reciprocity between the viral agent and the inclined host. Viruses are capable of causing a disease after contravening the host's elementary physical and natural protective barriers, evading all- local, tissue, and immune defenses that are spread across the host’s body and destroy cells directly or indirectly by the host’s immune and inflammatory responses. Viral pathogenesis is categorized into 7 stages, 1. Transmission  & entry of the virus into the host, 2. Spread of the viral agent in the host, 3. Tropism,  4.  Virulence, 5.  Paradigm of viral infections and diseases , 6.  Host factors,  and  7.  Host defenses.

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

9th International Virology Congress and Expo,March13-15,2017 London,UK;10^th World Congress on Virology and Mycology May 11-12,2017 Singapore;8^th World Congress on Virology,November 20-30,2016 San Anthonio,USA;5^th International Conference on HIV/AIDS,STDs and STIs November 13-14,2017 Las Vegas,Neveda,USA; American Society for Virology 2017 Annual Meeting 24-28 June 2017,Madison,United States; ICV2017:19^th International Conference on Virology,Miami,USA,March9-10,2017;GRC Physical Virology Gordon Research Conference,January29-February3,2017; ASM Clinical Virology Symposium,May7-10,2017,Savannah,Georgia; 27^th Annual Meeting of the Society for Virology,22-25 March 2017,Marburg; 4^th World Congress and Expo on Applied Microbiology September 19-21,2016 Las Vegas,USA; 7^th Clinical Microbiology Congress February 27-28,2017 Amsterdam,Netherlands ; 8^th Clinical Microbiology Conference October 26-27,2017 Paris,France; CACMID-AMMI Canada 2017 Annual Conference(Toronto,May 3-6 2017);asm microbe 2017; 27^th European Congress of Clinical Microbiology and Infectious Diseases 2017(ECCMID 2017); FEMS 2017 7^th Congress of European Microbiologists,July 9-13,2017 Valencia,Spain; The Microbiology Society Annual Conference 2017,3-6April 2017.

Track 3 : Anatomical Pathology

The global Anatomical Pathology and the Tissue Diagnostics market are predicted to grow at a CAGR of approximately 6.97% between the forecast period of 2013 and 2018, to acquire net worth of $3,924.01 Million by 2018.

Anatomical Pathology is typically concerned with the macroscopic, microscopic, biochemical, immunological & molecular probing of organs and tissues to diagnose an infection or a disease. In the recent times, surgical pathology has emerged eminently- we have seen the advancement in form of antecedent histological examination of diseases/affected parts, called autopsy to a more novel and neoteric practice focused on the diagnosis & prognosis to pilot treatment in oncology. Its advanced founder is the Italian scientist Giovan Battista Morgagni. The microscopic examination of probable infected specimens like tissue, cells, bodily fluids and secretions for diagnosis, omission, and scrutinizing of disease in the specimen is all a part of the Anatomical Pathology. The use of novel molecular tests for diagnosing viral infections is on the rise, because of the enhanced sensitivity and rapid result outcome capability of these methods. A myriad of high-end molecular techniques are now available for the identification and quantification of viruses. Molecular diagnostic tools in viral testing have measured a swift progress during recent years and have been adapted by several laboratories due to the ease and convenience in the diagnosis of viruses. These molecular techniques have greatly reduced the use of viral culture based methods and numerous serological assays in diagnosing the infectious viruses in the laboratory. Some of the advanced molecular techniques like Amplified & Non-Amplified Nucleic Acid Techniques, Microarrays, PCR based Techniques, and Target Amplification Techniques are typically employed in diagnosing a viral infection.

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

9th International Virology Congress and Expo,March13-15,2017 London,UK;10^th World Congress on Virology and Mycology May 11-12,2017 Singapore;8^th World Congress on Virology,November 20-30,2016 San Anthonio,USA;5^th International Conference on HIV/AIDS,STDs and STIs November 13-14,2017 Las Vegas,Neveda,USA; American Society for Virology 2017 Annual Meeting 24-28 June 2017,Madison,United States; ICV2017:19^th International Conference on Virology,Miami,USA,March9-10,2017;GRC Physical Virology Gordon Research Conference,January29-February3,2017; ASM Clinical Virology Symposium,May7-10,2017,Savannah,Georgia; 27^th Annual Meeting of the Society for Virology,22-25 March 2017,Marburg; 4^th World Congress and Expo on Applied Microbiology September 19-21,2016 Las Vegas,USA; 7^th Clinical Microbiology Congress February 27-28,2017 Amsterdam,Netherlands ; 8^th Clinical Microbiology Conference October 26-27,2017 Paris,France; CACMID-AMMI Canada 2017 Annual Conference(Toronto,May 3-6 2017);asm microbe 2017; 27^th European Congress of Clinical Microbiology and Infectious Diseases 2017(ECCMID 2017); FEMS 2017 7^th Congress of European Microbiologists,July 9-13,2017 Valencia,Spain; The Microbiology Society Annual Conference 2017,3-6April 2017.

 Track 4 : Immunohistochemistry

The Global Tissue Diagnostics Market overview was valued at $3,202.5 Million in 2015 and is envisaged to reach $4,471.1 Million by 2020 growing at a remarkable CAGR of about 6.9% in the forecast period of 2015 to 2020. The tissue diagnostics market heralds remarkable and affluent growth potential from 2015 with the major factor that drives the growth is the increasing ubiquity of cancer; while on the other hand, the high degree of consolidation, inflexible regulatory requirements, and dearth of budgets are exorbitating the global growth of this market. The tissue diagnostics categorized into immunohistochemistry (IHC), digital pathology, in-situ hybridization, workflow, and histo-staining. In 2015, the immunohistochemistry accounted for the largest stake in the global tissue diagnostics market with the technology segment of Tissue diagnostics mainly driven by IVD (in vitro diagnostics).

Immunohistochemistry, abbreviated as IHC is a potent method in localizing unambiguous antigens present in the Formalin Fixed, Paraffin Embedded (FFPE) tissues/ specimens predicated on the antigen–antibody interactions. The FFPE technique is extensively used in various research and diagnostics concerning dermatological and histological specimens; IHC’s applications expand continually primarily because of its convenience, reliability, and versatility. In IHC an antigen–antibody complex is explored through the light microscopy. The elementary advantage of IHC over immunofluorescence is the counterstaining which allows the visibility of the morphology of tissue around the antigen with hematoxylin. Results of stained markers are recorded semi-quantitatively and apparently have paramount diagnostic and prognostic implications for skin tumors, lymphoma, and also in the detection of infectious microorganisms in the infected specimens. IHC staining is largely used in the diagnosis of cancerous cells. 

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

9th International Virology Congress and Expo,March13-15,2017 London,UK;10^th World Congress on Virology and Mycology May 11-12,2017 Singapore;8^th World Congress on Virology,November 20-30,2016 San Anthonio,USA;5^th International Conference on HIV/AIDS,STDs and STIs November 13-14,2017 Las Vegas,Neveda,USA; American Society for Virology 2017 Annual Meeting 24-28 June 2017,Madison,United States; ICV2017:19^th International Conference on Virology,Miami,USA,March9-10,2017;GRC Physical Virology Gordon Research Conference,January29-February3,2017; ASM Clinical Virology Symposium,May7-10,2017,Savannah,Georgia; 27^th Annual Meeting of the Society for Virology,22-25 March 2017,Marburg; 4^th World Congress and Expo on Applied Microbiology September 19-21,2016 Las Vegas,USA; 7^th Clinical Microbiology Congress February 27-28,2017 Amsterdam,Netherlands ; 8^th Clinical Microbiology Conference October 26-27,2017 Paris,France; CACMID-AMMI Canada 2017 Annual Conference(Toronto,May 3-6 2017);asm microbe 2017; 27^th European Congress of Clinical Microbiology and Infectious Diseases 2017(ECCMID 2017); FEMS 2017 7^th Congress of European Microbiologists,July 9-13,2017 Valencia,Spain; The Microbiology Society Annual Conference 2017,3-6April 2017.

 Track 5 : Immunopathology

Immunopathology is an immune response concorded when a host is infected by a virus or a viral agent and in often cases can also cause fatalities. The forming of immune complexes in tissues induces inflammation. Circulating immune complexes are usually harmless, but when deposited in tissues can evoke glomerulonephritis, arthritis and vasculitis. Cytotoxic T cells display quite influential effects in vitro, but have very rarely caused acute tissue affliction/damage in vivo. Disruption of cells by antibody-complement complex by antibodies and K cells or even by NK cells portrays a murky role in viral pathology. Delayed hypersensitive T cells are more crucial in immunopathology primarily as they induce inflammation, cause cell infiltration and invoke macrophage-mediated damage to the infected cells. Viral immunopathology is extremely pre-eminent in specific chronic diseases of obscured etiology.

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

9th International Virology Congress and Expo,March13-15,2017 London,UK;10^th World Congress on Virology and Mycology May 11-12,2017 Singapore;8^th World Congress on Virology,November 20-30,2016 San Anthonio,USA;5^th International Conference on HIV/AIDS,STDs and STIs November 13-14,2017 Las Vegas,Neveda,USA; American Society for Virology 2017 Annual Meeting 24-28 June 2017,Madison,United States; ICV2017:19^th International Conference on Virology,Miami,USA,March9-10,2017;GRC Physical Virology Gordon Research Conference,January29-February3,2017; ASM Clinical Virology Symposium,May7-10,2017,Savannah,Georgia; 27^th Annual Meeting of the Society for Virology,22-25 March 2017,Marburg; 4^th World Congress and Expo on Applied Microbiology September 19-21,2016 Las Vegas,USA; 7^th Clinical Microbiology Congress February 27-28,2017 Amsterdam,Netherlands ; 8^th Clinical Microbiology Conference October 26-27,2017 Paris,France; CACMID-AMMI Canada 2017 Annual Conference(Toronto,May 3-6 2017);asm microbe 2017; 27^th European Congress of Clinical Microbiology and Infectious Diseases 2017(ECCMID 2017); FEMS 2017 7^th Congress of European Microbiologists,July 9-13,2017 Valencia,Spain; The Microbiology Society Annual Conference 2017,3-6April 2017.

 Track 6 : Diagnostic Virology & Molecular Analysis

Diagnostics market is still incipient and is predicted to reach $3.5 billion by 2020 from the radical value of $1.1 billion, growing at a CAGR of about 20% during the predicted period of 2014 to 2020. The Global Diagnostic Market is categorized based on indication, geography and technology.  The crucial drivers for this market are the discovery and increase in utilization and study of biomarkers and co-development of drugs and various therapies corresponding to these diagnostics. Nevertheless, the costs pertinent with drug development could contravene the growth of diagnostic market. Scope for this market prevails in progressing diagnostics for various infectious and hereditary conditions.

Diagnostic virology is now a crux in pathology and in medical practice. Various approaches are being optimized for the laboratory diagnosis of viral infections, antigen and nucleic acid detection, and serology. The technique of viral culturing is dwindling as novel immunological and molecular tests detect and provide accurate and more rapid results. In the last decade, both qualitative and the quantitative nucleic acid detection techniques has had an extensive impact on viral diagnostics.

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

9th International Virology Congress and Expo,March13-15,2017 London,UK;10^th World Congress on Virology and Mycology May 11-12,2017 Singapore;8^th World Congress on Virology,November 20-30,2016 San Anthonio,USA;5^th International Conference on HIV/AIDS,STDs and STIs November 13-14,2017 Las Vegas,Neveda,USA; American Society for Virology 2017 Annual Meeting 24-28 June 2017,Madison,United States; ICV2017:19^th International Conference on Virology,Miami,USA,March9-10,2017;GRC Physical Virology Gordon Research Conference,January29-February3,2017; ASM Clinical Virology Symposium,May7-10,2017,Savannah,Georgia; 27^th Annual Meeting of the Society for Virology,22-25 March 2017,Marburg; 4^th World Congress and Expo on Applied Microbiology September 19-21,2016 Las Vegas,USA; 7^th Clinical Microbiology Congress February 27-28,2017 Amsterdam,Netherlands ; 8^th Clinical Microbiology Conference October 26-27,2017 Paris,France; CACMID-AMMI Canada 2017 Annual Conference(Toronto,May 3-6 2017);asm microbe 2017; 27^th European Congress of Clinical Microbiology and Infectious Diseases 2017(ECCMID 2017); FEMS 2017 7^th Congress of European Microbiologists,July 9-13,2017 Valencia,Spain; The Microbiology Society Annual Conference 2017,3-6April 2017.

 Track 7 : Viral Hepatitis

Due to the extensive infection index of HCV and necessity for the progressive and enhanced therapies, there are a varied of assessments estimating that the global market for HCV is bound to reach $20 billion perennially by the end of this decade.

Hepatitis is a liver inflammation characterized by presence of inflammatory cells in the tissues and can be either acute or chronic, caused by viruses belonging to different families, other than Hepatitis viruses- Cytomegalovirus, Herpes simplex, Yellow fever and Epstein–Barr virus. Transmission of Hepatitis A virus and Hepatitis E virus is by enteral routes while Hepatitis B virus, Hepatitis C virus and Hepatitis D virus is by Parenteral routes.

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

9th International Virology Congress and Expo,March13-15,2017 London,UK;10^th World Congress on Virology and Mycology May 11-12,2017 Singapore;8^th World Congress on Virology,November 20-30,2016 San Anthonio,USA;5^th International Conference on HIV/AIDS,STDs and STIs November 13-14,2017 Las Vegas,Neveda,USA; American Society for Virology 2017 Annual Meeting 24-28 June 2017,Madison,United States; ICV2017:19^th International Conference on Virology,Miami,USA,March9-10,2017;GRC Physical Virology Gordon Research Conference,January29-February3,2017; ASM Clinical Virology Symposium,May7-10,2017,Savannah,Georgia; 27^th Annual Meeting of the Society for Virology,22-25 March 2017,Marburg; 4^th World Congress and Expo on Applied Microbiology September 19-21,2016 Las Vegas,USA; 7^th Clinical Microbiology Congress February 27-28,2017 Amsterdam,Netherlands ; 8^th Clinical Microbiology Conference October 26-27,2017 Paris,France; CACMID-AMMI Canada 2017 Annual Conference(Toronto,May 3-6 2017);asm microbe 2017; 27^th European Congress of Clinical Microbiology and Infectious Diseases 2017(ECCMID 2017); FEMS 2017 7^th Congress of European Microbiologists,July 9-13,2017 Valencia,Spain; The Microbiology Society Annual Conference 2017,3-6April 2017.

Track 8 : Biology of Sexually Transmitted Diseases

The global market for biology of sexually transmitted diseases was valued at $33.3 billion in 2012 and the total market net worth is envisaged to reach $52 billion in 2017 at a CAGR of about 9.3%.

STDs, or rather STIs (Sexually Transmitted Infections) hold a crucial global health prominence because of their overwhelming - emotional, mental and physical impact on women and in infants. Infections with few STDs can accentuate the risk of contracting and transmitting HIV and modify the course of the disease progression. Besides, STDs can also cause chronic health implications, notably in women and infants. Some of the health implications of STDs comprises of cervical cancer, infertility, pelvic inflammatory disease, tubal or ectopic pregnancy and perinatal or congenital infections in infants born to indisposed mothers. A sexually transmitted disease (STD), also called venereal diseases (VD), is a disease which typically transmits through some form of sexual contact, but not necessarily only this mode of transmission. STDs can also be transmitted from infected blood transfusion, from mother to child or also through transmission of bodily fluids, but commonly by sex, especially vaginal intercourse, anal sex and oral sex. As most STIs initially are asymptomatic, which result in an augmented outcome of transmitting the disease to others. Most STIs are treatable or curable; but herpes, hepatitis B, HIV/AIDS, and HPV are only treatable but not curable.

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

9th International Virology Congress and Expo,March13-15,2017 London,UK;10^th World Congress on Virology and Mycology May 11-12,2017 Singapore;8^th World Congress on Virology,November 20-30,2016 San Anthonio,USA;5^th International Conference on HIV/AIDS,STDs and STIs November 13-14,2017 Las Vegas,Neveda,USA; American Society for Virology 2017 Annual Meeting 24-28 June 2017,Madison,United States; ICV2017:19^th International Conference on Virology,Miami,USA,March9-10,2017;GRC Physical Virology Gordon Research Conference,January29-February3,2017; ASM Clinical Virology Symposium,May7-10,2017,Savannah,Georgia; 27^th Annual Meeting of the Society for Virology,22-25 March 2017,Marburg; 4^th World Congress and Expo on Applied Microbiology September 19-21,2016 Las Vegas,USA; 7^th Clinical Microbiology Congress February 27-28,2017 Amsterdam,Netherlands ; 8^th Clinical Microbiology Conference October 26-27,2017 Paris,France; CACMID-AMMI Canada 2017 Annual Conference(Toronto,May 3-6 2017);asm microbe 2017; 27^th European Congress of Clinical Microbiology and Infectious Diseases 2017(ECCMID 2017); FEMS 2017 7^th Congress of European Microbiologists,July 9-13,2017 Valencia,Spain; The Microbiology Society Annual Conference 2017,3-6April 2017.

Track 9 : Hemorrhagic Fever

The global market for Hemorrhagic Fever is envisaged to reach $56 million by 2020 at a remarkable CAGR of about 95.2% in the forecast period of 2015-2020.

Viral hemorrhagic fevers, abbreviated as VHFs are an aggregate of illnesses elicited by four families of viruses – Ebola, Marburg, Lassa fever, and yellow fever viruses. VHFs affect organs, damage blood vessels, and disturbs the body's competence to regulate itself; while some VHFs cause only mild fever, but others, for instance, Ebola or Marburg, are fatal. VHFs are global; while some are specific to the areas where animal vectors are in abundance.

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

9th International Virology Congress and Expo,March13-15,2017 London,UK;10^th World Congress on Virology and Mycology May 11-12,2017 Singapore;8^th World Congress on Virology,November 20-30,2016 San Anthonio,USA;5^th International Conference on HIV/AIDS,STDs and STIs November 13-14,2017 Las Vegas,Neveda,USA; American Society for Virology 2017 Annual Meeting 24-28 June 2017,Madison,United States; ICV2017:19^th International Conference on Virology,Miami,USA,March9-10,2017;GRC Physical Virology Gordon Research Conference,January29-February3,2017; ASM Clinical Virology Symposium,May7-10,2017,Savannah,Georgia; 27^th Annual Meeting of the Society for Virology,22-25 March 2017,Marburg; 4^th World Congress and Expo on Applied Microbiology September 19-21,2016 Las Vegas,USA; 7^th Clinical Microbiology Congress February 27-28,2017 Amsterdam,Netherlands ; 8^th Clinical Microbiology Conference October 26-27,2017 Paris,France; CACMID-AMMI Canada 2017 Annual Conference(Toronto,May 3-6 2017);asm microbe 2017; 27^th European Congress of Clinical Microbiology and Infectious Diseases 2017(ECCMID 2017); FEMS 2017 7^th Congress of European Microbiologists,July 9-13,2017 Valencia,Spain; The Microbiology Society Annual Conference 2017,3-6April 2017.

Track 10 : Tumor Virology

The global Tumor Virology Market was at its remarkable at $14.99 billion and is envisaged to reach around $35 billion by 2018, developing at a significant CAGR of 18.5% in the predicted period of 2013 to 2018.

Viruses that cause or initiate cancers are called oncoviruses or oncornaviruses- as it was initially thought that only viruses with RNA origin cause cancers- but it now denotes any virus with either a DNA or a RNA genome initiating cancer and is now analogous to tumor virus or cancer virus. Multitude human and animal viruses generally do not evoke cancer because of archaic co-evolution between virus and humans.

World Health Organization's (WHO) -  International Agency for Research on Cancer (IARC), in 2002 reported that approximately 17.8% of all human cancers were infection-initiated, with 11.9% of them being caused by viruses. Although these cancers can be easily prevented through vaccination, but only if diagnosed early with simple blood tests, and are then treated with less-toxic antivirals.

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

9th International Virology Congress and Expo,March13-15,2017 London,UK;10^th World Congress on Virology and Mycology May 11-12,2017 Singapore;8^th World Congress on Virology,November 20-30,2016 San Anthonio,USA;5^th International Conference on HIV/AIDS,STDs and STIs November 13-14,2017 Las Vegas,Neveda,USA; American Society for Virology 2017 Annual Meeting 24-28 June 2017,Madison,United States; ICV2017:19^th International Conference on Virology,Miami,USA,March9-10,2017;GRC Physical Virology Gordon Research Conference,January29-February3,2017; ASM Clinical Virology Symposium,May7-10,2017,Savannah,Georgia; 27^th Annual Meeting of the Society for Virology,22-25 March 2017,Marburg; 4^th World Congress and Expo on Applied Microbiology September 19-21,2016 Las Vegas,USA; 7^th Clinical Microbiology Congress February 27-28,2017 Amsterdam,Netherlands ; 8^th Clinical Microbiology Conference October 26-27,2017 Paris,France; CACMID-AMMI Canada 2017 Annual Conference(Toronto,May 3-6 2017);asm microbe 2017; 27^th European Congress of Clinical Microbiology and Infectious Diseases 2017(ECCMID 2017); FEMS 2017 7^th Congress of European Microbiologists,July 9-13,2017 Valencia,Spain; The Microbiology Society Annual Conference 2017,3-6April 2017.

Track 11 : Viral Infections of Oral Cavity

Viral diseases/infections of the oral cavity, oral mucosa and perioral regions are generally encountered by dentists and have not received the required recognition until recently and viruses are both - ulcerogenic and the tumorigenic agents of human oral cavity. The plethora of mammalian viruses in the lesions seen in periodontitis proposes that viruses play a significant role in oral diseases than earlier recognized. One of the most crucial target of oral microbiology in future would be to arbitrate the diversity, magnitude, frequency, pathogenicity, treatment and prognosis of oral viruses and the infections they cause.

Human Herpes virus (HHV) and Human Papillomavirus (HPV) are liable for the most prevalent primary viral infections; with HPV having received crucial scrutiny, as high-risk strains of HPV have been associated with few cases of oral squamous cell carcinoma. However there are numerous other viruses that can cause oral infections in the oral cavity. Some of the viruses that are associated with oral cavity diseases/infections are Cox Sackie Virus, HHV, HPV, Measles Virus, Mumps Virus and Rubella Virus.

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

9th International Virology Congress and Expo,March13-15,2017 London,UK;10^th World Congress on Virology and Mycology May 11-12,2017 Singapore;8^th World Congress on Virology,November 20-30,2016 San Anthonio,USA;5^th International Conference on HIV/AIDS,STDs and STIs November 13-14,2017 Las Vegas,Neveda,USA; American Society for Virology 2017 Annual Meeting 24-28 June 2017,Madison,United States; ICV2017:19^th International Conference on Virology,Miami,USA,March9-10,2017;GRC Physical Virology Gordon Research Conference,January29-February3,2017; ASM Clinical Virology Symposium,May7-10,2017,Savannah,Georgia; 27^th Annual Meeting of the Society for Virology,22-25 March 2017,Marburg; 4^th World Congress and Expo on Applied Microbiology September 19-21,2016 Las Vegas,USA; 7^th Clinical Microbiology Congress February 27-28,2017 Amsterdam,Netherlands ; 8^th Clinical Microbiology Conference October 26-27,2017 Paris,France; CACMID-AMMI Canada 2017 Annual Conference(Toronto,May 3-6 2017);asm microbe 2017; 27^th European Congress of Clinical Microbiology and Infectious Diseases 2017(ECCMID 2017); FEMS 2017 7^th Congress of European Microbiologists,July 9-13,2017 Valencia,Spain; The Microbiology Society Annual Conference 2017,3-6April 2017.

 Track 12 : New Innovations in Viral Infections

Viral Outbreaks generally are pandemic, mostly transmitted via tourists, especially air travelers. These outbreaks have a very serious and hard impact on the global economy. These impacts can be of short term and long term. These impacts sometimes are so severe that it causes about 80% financial impact globally; in the recent Ebola outbreak in 2015, the short term impact was an estimated $359 million in Guinea, Sierra Leone and Liberia alone, which were the severe worst it countries, with the long term impact being $809 million.

Infectious diseases pose a severe threat to global population health and are majorly devastating for the tropical countries as these infectious agents can easily thrive on those climatic conditions. The ease of international travel is one of the primary cause that is liable for transmission of these infectious agents from tropical to temperate and in some cases, also to the polar zones of the world; mainly because of global warming.

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

9th International Virology Congress and Expo,March13-15,2017 London,UK;10^th World Congress on Virology and Mycology May 11-12,2017 Singapore;8^th World Congress on Virology,November 20-30,2016 San Anthonio,USA;5^th International Conference on HIV/AIDS,STDs and STIs November 13-14,2017 Las Vegas,Neveda,USA; American Society for Virology 2017 Annual Meeting 24-28 June 2017,Madison,United States; ICV2017:19^th International Conference on Virology,Miami,USA,March9-10,2017;GRC Physical Virology Gordon Research Conference,January29-February3,2017; ASM Clinical Virology Symposium,May7-10,2017,Savannah,Georgia; 27^th Annual Meeting of the Society for Virology,22-25 March 2017,Marburg; 4^th World Congress and Expo on Applied Microbiology September 19-21,2016 Las Vegas,USA; 7^th Clinical Microbiology Congress February 27-28,2017 Amsterdam,Netherlands ; 8^th Clinical Microbiology Conference October 26-27,2017 Paris,France; CACMID-AMMI Canada 2017 Annual Conference(Toronto,May 3-6 2017);asm microbe 2017; 27^th European Congress of Clinical Microbiology and Infectious Diseases 2017(ECCMID 2017); FEMS 2017 7^th Congress of European Microbiologists,July 9-13,2017 Valencia,Spain; The Microbiology Society Annual Conference 2017,3-6April 2017.

 Track 13 :  Multi-pathogen Infections

Multiple pathogens sometimes coexist resulting in polyparasitism, which leads to augmented infectivity and diseased condition, modified pathogen load, and emphasis in pathogenesis. For instance, Burkitt's lymphoma is commonly found in regions with high malarial transmittance and it is reported that malaria-induced immune response is linked with the evolution of lymphomas.  These organisms are termed opportunistic infectious agents, and are liable for high morbidity and mortality rates. HIV is one of the opportunistic organisms with high potential to interact with other infectious organisms like parasitic, viral, fungal, and bacterial agents.

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

9th International Virology Congress and Expo,March13-15,2017 London,UK;10^th World Congress on Virology and Mycology May 11-12,2017 Singapore;8^th World Congress on Virology,November 20-30,2016 San Anthonio,USA;5^th International Conference on HIV/AIDS,STDs and STIs November 13-14,2017 Las Vegas,Neveda,USA; American Society for Virology 2017 Annual Meeting 24-28 June 2017,Madison,United States; ICV2017:19^th International Conference on Virology,Miami,USA,March9-10,2017;GRC Physical Virology Gordon Research Conference,January29-February3,2017; ASM Clinical Virology Symposium,May7-10,2017,Savannah,Georgia; 27^th Annual Meeting of the Society for Virology,22-25 March 2017,Marburg; 4^th World Congress and Expo on Applied Microbiology September 19-21,2016 Las Vegas,USA; 7^th Clinical Microbiology Congress February 27-28,2017 Amsterdam,Netherlands ; 8^th Clinical Microbiology Conference October 26-27,2017 Paris,France; CACMID-AMMI Canada 2017 Annual Conference(Toronto,May 3-6 2017);asm microbe 2017; 27^th European Congress of Clinical Microbiology and Infectious Diseases 2017(ECCMID 2017); FEMS 2017 7^th Congress of European Microbiologists,July 9-13,2017 Valencia,Spain; The Microbiology Society Annual Conference 2017,3-6April 2017.

Track 14 :  Vaccines : Advancements

The global market overview of antiviral drugs, therapies and vaccines is categorized depending on antivirals like Hepatitis-C, HIV , Herpes, Hepatitis-B, Influenza and other antivirals. Some of the crucial aspects that drive the antiviral markets are advances in R&D activities, augmentation in healthcare concerns, awareness and expenditure, increased pervasiveness of ominous viral diseases. According to the market reports, the global antiviral industry- therapies, drugs and vaccines was net worth $4.1 billion for 2013, and it is estimated to reach nearly $6 billion in 2018, growing at a CAGR of 8% in the forecast period of 2013-2018.

Antiviral drugs and vaccines are a class of antimicrobials, which also includes antibiotics and drugs which are solely monoclonal antibodies. Unlike antibacterials, most antivirals are relatively harmless and can be used to treat numerous viral infections.

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

9th International Virology Congress and Expo,March13-15,2017 London,UK;10^th World Congress on Virology and Mycology May 11-12,2017 Singapore;8^th World Congress on Virology,November 20-30,2016 San Anthonio,USA;5^th International Conference on HIV/AIDS,STDs and STIs November 13-14,2017 Las Vegas,Neveda,USA; American Society for Virology 2017 Annual Meeting 24-28 June 2017,Madison,United States; ICV2017:19^th International Conference on Virology,Miami,USA,March9-10,2017;GRC Physical Virology Gordon Research Conference,January29-February3,2017; ASM Clinical Virology Symposium,May7-10,2017,Savannah,Georgia; 27^th Annual Meeting of the Society for Virology,22-25 March 2017,Marburg; 4^th World Congress and Expo on Applied Microbiology September 19-21,2016 Las Vegas,USA; 7^th Clinical Microbiology Congress February 27-28,2017 Amsterdam,Netherlands ; 8^th Clinical Microbiology Conference October 26-27,2017 Paris,France; CACMID-AMMI Canada 2017 Annual Conference(Toronto,May 3-6 2017);asm microbe 2017; 27^th European Congress of Clinical Microbiology and Infectious Diseases 2017(ECCMID 2017); FEMS 2017 7^th Congress of European Microbiologists,July 9-13,2017 Valencia,Spain; The Microbiology Society Annual Conference 2017,3-6April 2017.

Track 15 :  Clinical Course of Viral Infections

The Global Infectious Virology Market reported the net worth of $1485.02 million in 2013 and is predicted to reach $1932.8 million by 2018, growing at a CAGR of about 5.6 and is  predicted to grow with a remarkable CAGR growth of about 7% through the forecast period of 2016-2021.

Clinical course of an infection is the behavioral pattern of a virus inside a host after the onset of the infection and how it evolves overtime. It may be per-acute, acute, sub-acute, chronic or intermittent. A deep-rooted knowledge on the clinical Course is essential to understand the disease and the behavioral pattern of the viral agent and to hinder it’s growth which would ultimately lead in hindering the spread of the infection.

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

9th International Virology Congress and Expo,March13-15,2017 London,UK;10^th World Congress on Virology and Mycology May 11-12,2017 Singapore;8^th World Congress on Virology,November 20-30,2016 San Anthonio,USA;5^th International Conference on HIV/AIDS,STDs and STIs November 13-14,2017 Las Vegas,Neveda,USA; American Society for Virology 2017 Annual Meeting 24-28 June 2017,Madison,United States; ICV2017:19^th International Conference on Virology,Miami,USA,March9-10,2017;GRC Physical Virology Gordon Research Conference,January29-February3,2017; ASM Clinical Virology Symposium,May7-10,2017,Savannah,Georgia; 27^th Annual Meeting of the Society for Virology,22-25 March 2017,Marburg; 4^th World Congress and Expo on Applied Microbiology September 19-21,2016 Las Vegas,USA; 7^th Clinical Microbiology Congress February 27-28,2017 Amsterdam,Netherlands ; 8^th Clinical Microbiology Conference October 26-27,2017 Paris,France; CACMID-AMMI Canada 2017 Annual Conference(Toronto,May 3-6 2017);asm microbe 2017; 27^th European Congress of Clinical Microbiology and Infectious Diseases 2017(ECCMID 2017); FEMS 2017 7^th Congress of European Microbiologists,July 9-13,2017 Valencia,Spain; The Microbiology Society Annual Conference 2017,3-6April 2017.

Track 16 : Anti-Viral Agents and Treatments

The Universal Therapeutic Industry at a predicted worth of $1485.02 million in 2013 is expected to reach $1932.8 million by 2018 growing at a CAGR of 5.6%.

Virotherapy is a sub-field of Virology and therapeutics, which uses biotechnology as a means to convert viruses into required therapeutic agents by reprogramming the genome and other metabolic pathways of viruses to treat diseases. There are 3 categories of virotherapy as of now:

1. Anti-cancer oncolytic viruses,

2. Viral vectors for gene therapy and

3. Viral immunotherapy.

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

2^nd International Conference on Antimicrobial Agents and Chemotherapy October 19-20, 2017 Atlanta, Georgia, USA; 4^th World Microbiologists Annual Conference June 22-23, 2017 Philadelphia, USA; 7^th Clinical Microbiology Congress February 27-28, 2017 Amsterdam, Netherlands; The ICMMAAC 2017: 19th International Conference on Medical Microbiology, Antimicrobial Agents and Chemotherapy,May25-26,2017,London,United Kingdom; The Microbiology Society Annual Conference 2017; World Antimicrobial Resistance Congress 2017,14-15September,Washington,DC.

Track 17 : Nanobiotechnology in Virotherapy

Viral Bionanotechnology is still a nascent field, but it is gradually gaining popularity, especially with the automatic parallel formation of viral building blocks is in the hand’s reach after the recent progress of chip-based DNA manipulation to the cell-cultured techniques. The researchers are on the verge of accomplishing the generation of virus-based nanoparticles, multi-layered arrays & hybrid virus networks by incorporation of quantum dots and carbon nanotubes (CNTs). They are also researching the use of virus-like protein cages to form novel materials that can be safely and cost-effectively used for biomedical applications such as biomedical imaging.

Researchers commonly use viruses as the means of vectors to introduce genes into the host cells and typically also as a carrier in gene therapy, after having genetically modified to carry out the activities of a normal human DNA, they also are capable of delivering therapeutic genes to the target cells. Present trends in nanobiotechnology is sure to take virus nanobiotechnology to new heights; Viruses are regarded as organic nanoparticles as their surface has definite tools which are capable of crossing the barriers of the host cells. These impressive and massive approaches of life-sciences in association with chemistry, physics and engineering have become the foundation of modern bio-physical medicine and are opening a wide spectrum of approaches in all these pure and applied fields.

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

9th International Virology Congress and Expo,March13-15,2017 London,UK;10^th World Congress on Virology and Mycology May 11-12,2017 Singapore;8^th World Congress on Virology,November 20-30,2016 San Anthonio,USA;5^th International Conference on HIV/AIDS,STDs and STIs November 13-14,2017 Las Vegas,Neveda,USA; American Society for Virology 2017 Annual Meeting 24-28 June 2017,Madison,United States; ICV2017:19^th International Conference on Virology,Miami,USA,March9-10,2017;GRC Physical Virology Gordon Research Conference,January29-February3,2017; ASM Clinical Virology Symposium,May7-10,2017,Savannah,Georgia; 27^th Annual Meeting of the Society for Virology,22-25 March 2017,Marburg; 4^th World Congress and Expo on Applied Microbiology September 19-21,2016 Las Vegas,USA; 7^th Clinical Microbiology Congress February 27-28,2017 Amsterdam,Netherlands ; 8^th Clinical Microbiology Conference October 26-27,2017 Paris,France; CACMID-AMMI Canada 2017 Annual Conference(Toronto,May 3-6 2017);asm microbe 2017; 27^th European Congress of Clinical Microbiology and Infectious Diseases 2017(ECCMID 2017); FEMS 2017 7^th Congress of European Microbiologists,July 9-13,2017 Valencia,Spain; The Microbiology Society Annual Conference 2017,3-6April 2017.

Track 18: Novel Research in Clinical Virology

The global stem cell therapy industry is expected to grow at a CAGR of 39.5% from 2015 to 2020 to reach an estimated $330million by 2020; while the global virology market is expected to reach $1932.8 million by 2018, growing at a CAGR of 5.6%.

Stem cell therapy, one of the widely used therapies and the most researched field in virology uses stem cells to impede a disease or an infection. Bone marrow transplantation is largely executed stem cell therapy. Clinical virology is an intermediary field of medicine comprising of isolating and/or characterizing viruses responsible for various human pathologies by either direct or indirect approaches.

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

9th International Virology Congress and Expo,March13-15,2017 London,UK;10^th World Congress on Virology and Mycology May 11-12,2017 Singapore;8^th World Congress on Virology,November 20-30,2016 San Anthonio,USA;5^th International Conference on HIV/AIDS,STDs and STIs November 13-14,2017 Las Vegas,Neveda,USA; American Society for Virology 2017 Annual Meeting 24-28 June 2017,Madison,United States; ICV2017:19^th International Conference on Virology,Miami,USA,March9-10,2017;GRC Physical Virology Gordon Research Conference,January29-February3,2017; ASM Clinical Virology Symposium,May7-10,2017,Savannah,Georgia; 27^th Annual Meeting of the Society for Virology,22-25 March 2017,Marburg; 4^th World Congress and Expo on Applied Microbiology September 19-21,2016 Las Vegas,USA; 7^th Clinical Microbiology Congress February 27-28,2017 Amsterdam,Netherlands ; 8^th Clinical Microbiology Conference October 26-27,2017 Paris,France; CACMID-AMMI Canada 2017 Annual Conference(Toronto,May 3-6 2017);asm microbe 2017; 27^th European Congress of Clinical Microbiology and Infectious Diseases 2017(ECCMID 2017); FEMS 2017 7^th Congress of European Microbiologists,July 9-13,2017 Valencia,Spain; The Microbiology Society Annual Conference 2017,3-6April 2017.

Track 19 :Veterinary Virology

The global animal healthcare market was esteemed at USD 27,861.2 million in 2013 and is expected to grow at a CAGR of 7.1% from 2014 to 2019, to achieve an expected estimation of USD 41,929.1 million in 2019.

Veterinary virology is the investigation of viruses in animals. It is a critical branch of Veterinary medicine. An emerging virus is a term connected to a new found virus, one that is increasing in occurrence or with the possibility to increment in rate. Zoonotic diseases /contamination's are those which can be actually transmissible from vertebrate animals to humans. Prion disease represents to a group of conditions that influence the nervous system in humans and animals. 

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

9th International Virology Congress and Expo,March13-15,2017 London,UK;10^th World Congress on Virology and Mycology May 11-12,2017 Singapore;8^th World Congress on Virology,November 20-30,2016 San Anthonio,USA;5^th International Conference on HIV/AIDS,STDs and STIs November 13-14,2017 Las Vegas,Neveda,USA; American Society for Virology 2017 Annual Meeting 24-28 June 2017,Madison,United States; ICV2017:19^th International Conference on Virology,Miami,USA,March9-10,2017;GRC Physical Virology Gordon Research Conference,January29-February3,2017; ASM Clinical Virology Symposium,May7-10,2017,Savannah,Georgia; 27^th Annual Meeting of the Society for Virology,22-25 March 2017,Marburg; 4^th World Congress and Expo on Applied Microbiology September 19-21,2016 Las Vegas,USA; 7^th Clinical Microbiology Congress February 27-28,2017 Amsterdam,Netherlands ; 8^th Clinical Microbiology Conference October 26-27,2017 Paris,France; CACMID-AMMI Canada 2017 Annual Conference(Toronto,May 3-6 2017);asm microbe 2017; 27^th European Congress of Clinical Microbiology and Infectious Diseases 2017(ECCMID 2017); FEMS 2017 7^th Congress of European Microbiologists,July 9-13,2017 Valencia,Spain; The Microbiology Society Annual Conference 2017,3-6April 2017.

Track 20 :Plant Virology

The agricultural inoculants industry when quoted in appraisal is envisaged to reach about $398.56 million by the year 2019, at a CAGR of about 9.5% from 2014.

The epidemiology of plant virus diseases obligates the cyclical development of virus diseases visceral to plant populace in time and expanse. Tobacco mosaic virus (TMV) is a positive-sense single stranded RNA virus that infects an extensive expanse of plants, principally tobacco and other members of the family Solanaceae. Mycology is the field of biology which accords with the study and research on fungi, constituting their genetic, biochemical properties, taxonomy & their use to humans as a reservoir for tinder, medicine, wine and various entheogens, as well as the perils like poisoning/noxiousity or infection. Viruses exist as obligate intracellular parasites and hence they ought to accomplish unambiguous approaches of transmission, between hosts, in order to endure. 75% of plant viruses have genomes that compose single stranded RNA (ssRNA). 65% of plant viruses have +ssRNA, in essence that they are in the same sense proclivity as messenger RNA but 10% have -ssRNA, in essence they ought to be converted to +ssRNA precedently to being translated. 5% are double stranded RNA and so can be promptly translated as +ssRNA viruses.

Related Virology Conferences | Clinical Virology Conferences | ConferenceSeries Ltd

9th International Virology Congress and Expo,March13-15,2017 London,UK;10^th World Congress on Virology and Mycology May 11-12,2017 Singapore;8^th World Congress on Virology,November 20-30,2016 San Anthonio,USA;5^th International Conference on HIV/AIDS,STDs and STIs November 13-14,2017 Las Vegas,Neveda,USA; American Society for Virology 2017 Annual Meeting 24-28 June 2017,Madison,United States; ICV2017:19^th International Conference on Virology,Miami,USA,March9-10,2017;GRC Physical Virology Gordon Research Conference,January29-February3,2017; ASM Clinical Virology Symposium,May7-10,2017,Savannah,Georgia; 27^th Annual Meeting of the Society for Virology,22-25 March 2017,Marburg; 4^th World Congress and Expo on Applied Microbiology September 19-21,2016 Las Vegas,USA; 7^th Clinical Microbiology Congress February 27-28,2017 Amsterdam,Netherlands ; 8^th Clinical Microbiology Conference October 26-27,2017 Paris,France; CACMID-AMMI Canada 2017 Annual Conference(Toronto,May 3-6 2017);asm microbe 2017; 27^th European Congress of Clinical Microbiology and Infectious Diseases 2017(ECCMID 2017); FEMS 2017 7^th Congress of European Microbiologists,July 9-13,2017 Valencia,Spain; The Microbiology Society Annual Conference 2017,3-6April 2017.

Track 21 :Marine Virology

Over the past two decades, marine virology has progressed from a curiosity to an intensely studied topic of critical importance to oceanography. At concentrations of approximately 10 million viruses per milliliter of surface seawater, viruses are the most abundant biological entities in the oceans. The majority of these viruses are phages (viruses that infect bacteria). Through lysing their bacterial hosts, marine phages control bacterial abundance, affect community composition, and impact global biogeochemical cycles. In addition, phages influence their hosts through selection for resistance, horizontal gene transfer, and manipulation of bacterial metabolism. Marine viruses have important roles  in microbial mortality,gene transfer,metabolic reprogramming and biogeochemical cycling.

Entrepreneur Investments Meet:   Description

A key ingredient in successful entrepreneurship is self-knowledge. (Water Microbiology-2016) aims to bring together all existing and budding bio entrepreneurs to share experiences and present innovations and challenges in microbiological community. Each year, over a million companies are started in the world with about 5–10 of them classified as high technology companies. Turning ideas into business ventures is tricky and the opportunity-recognition step is critical in new venture creation. This gestalt in the entrepreneur's perception of the relationship between the invention and final product is refined into a business model that describes how the venture will make money or provide an appropriate return to the potential investors. Biological science is complex and rapidly changing and requires a specialized knowledge to understand the value of the innovation and its competitive position in the industry. Although life scientists are typically the founders of biotech companies, studies have shown that the most successful high tech startups are founded by a team of two to three individuals with mixed backgrounds, substantial industry experience and a very clear market and product focus at founding. This three day community-wide conference will be a highly interactive forum that will bring experts in areas ranging from structural microbiology to signaling pathways to novel therapeutic approaches to the scientific hub. In addition to our outstanding speakers, we will also showcase short talks and poster presentations from submitted abstracts. The speakers will discuss how microbes can be engineered to report using computational inputs from their local environment. This session will include combined efforts of cutting edge synthetic biology research to highlight the current state, challenges and future of engineered microbial communities.